Technology | February 24, 2012

Wisconsin Heart Hospital First to Use Leonardo 3-D Vision System For Da Vinci Robot


February 24, 2012 — 3-D Surgical Solutions LLC and Wheaton Franciscan-The Wisconsin Heart Hospital Campus announced that the first case ever using the Leonardo 3-D vision system was successfully conducted in a surgical robotic procedure. This revolutionary system provides stereoscopic 3-D visualization to personnel at the bedside – as well as the entire surgical robotic team -- during the surgery. The Leonardo 3-D vision system was used in conjunction with the Da Vinci surgical system from Intuitive Surgical Inc.

"Today's case demonstrates a culmination of years of research and development that bring a new level of 3-D visualization to the operating room," said Husam Balkhy, M.D., chairman of cardiothoracic surgery and director, Center for Robotic and Minimally Invasive Cardiac Surgery at The Wisconsin Heart Hospital.

Balkhy and his medical team utilized the Leonardo 3-D vision system while performing a beating heart totally endoscopic coronary artery bypass (TECAB). This event marks a major milestone in the expansion of stereoscopic 3-D visualization within the robotic and video-assisted surgical fields and is a breakthrough in the availability of high-quality surgical imaging. This technology can be used with other cases using the Da Vinci Surgical System, including urology and gynecology procedures.

"For me, having such wonderfully crisp 3-D images to work with is exciting and extremely helpful," added Dorothy Krienbring, Balkhy's first assistant. "It allows me to introduce instruments and supplies into the chest with safety and with much more accuracy. Using this system allows all of us to see the anatomy in spectacular detail. The Leonardo system is a major step forward in the field of endoscopic surgery."

In addition, the Atlanticus 3-D recorder (a component of the vision system) was used during the case to digitally record stereoscopic 3-D/HD video for presentation at symposia, other clinically-oriented events, and teaching purposes.

"The versatility of this system is impressive, and the opportunity for optimized teaching that it represents is sure to provide enhanced safety as well as substantial cost and time savings to the operative and surgical training arena," Balkhy said.

For more information: www.mywheaton.org/hearthospital


Related Content

News | Cardiovascular Surgery

April 23, 2024 — Medtronic plc, a global leader in healthcare technology, today announced the launch of its latest ...

Home April 23, 2024
Home
News | Cardiovascular Surgery

March 20, 2024 — PECA Labs, a medical device company reimagining the field of vascular grafts and valves with durable ...

Home March 20, 2024
Home
News | Cardiovascular Surgery

February 26, 2024 — Hackensack Meridian Jersey Shore University Medical Center and Hackensack University Medical Center ...

Home February 26, 2024
Home
Feature | Cardiovascular Surgery

The DAIC team has learned of the passing of Alain Cribier, MD, FACC, heralded as the man who pioneered the first ...

Home February 23, 2024
Home
News | Cardiovascular Surgery

January 29, 2024 — Despite national guidelines recommending surgical aortic valve replacement (SAVR) for patients under ...

Home January 29, 2024
Home
News | Cardiovascular Surgery

January 11, 2024 — Paragonix Technologies, a pioneer in organ transplant solutions, is proud to announce the publication ...

Home January 11, 2024
Home
News | Cardiovascular Surgery

December 20, 2023 — The Smidt Heart Institute at Cedars-Sinai has opened an Aortic Surveillance Clinic for the ...

Home December 20, 2023
Home
News | Cardiovascular Surgery

December 18, 2023 — The Department of Cardiovascular Surgery at The Mount Sinai Hospital has received the highest ...

Home December 18, 2023
Home
News | Cardiovascular Surgery

November 2, 2023 — The University of Maryland Medical Center (UMMC) released a statement on the passing of a patient ...

Home November 02, 2023
Home
News | Cardiovascular Surgery

October 25, 2023 — Edwards Lifesciences announced new data from the PARTNER 3 trial demonstrating continued low rates of ...

Home October 25, 2023
Home
Subscribe Now